Strive Expands ATM Programs to $5.15B, Authorizes 40M Preferred Shares
Summary
Strive, Inc. has expanded its ATM programs to a combined $5.15 billion for common and preferred stock, a highly dilutive move, and increased authorized preferred shares to 40 million.
Key Events
-
Expanded Common Stock ATM Program
The company amended and restated its existing ATM program for common stock, authorizing the sale of up to $2.55 billion in Class A common stock from time to time.
-
New Preferred Stock ATM Program
A new ATM program for Variable Rate Series A Perpetual Preferred Stock was established, allowing the company to sell up to $2.6 billion in preferred shares from time to time.
-
Increased Preferred Share Authorization
The total authorized shares of Variable Rate Series A Perpetual Preferred Stock were increased to 40,000,000 shares, providing the necessary headroom for the new preferred stock ATM program.
-
Massive Potential Dilution
The combined potential offering of $5.15 billion represents over 500% of the company's current market capitalization, indicating extreme potential dilution for existing shareholders if fully utilized.
Analysis
Strive, Inc. has significantly expanded its "at-the-market" (ATM) equity programs, now authorizing the potential sale of up to $2.55 billion in common stock and $2.6 billion in preferred stock, totaling $5.15 billion. This substantial capital raise, which is over five times the company's current market capitalization, indicates a highly dilutive strategy. Concurrently, the company increased its authorized Variable Rate Series A Perpetual Preferred Stock to 40 million shares, providing the necessary headroom for the new preferred stock ATM program. This follows previous dilutive capital raises and signals a continued reliance on equity financing, which could exert significant downward pressure on both common and preferred share prices if fully utilized.
At the time of this filing, ASST was trading at $14.58 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $1B. The 52-week trading range was $7.02 to $252.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.